Digitisation | September 13, 2023
AI to transform all processes in drug development by 2026, predicts CPHI Report
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The products will be manufactured at the company's facility in Bengaluru
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
The company will develop and produce premixes for human nutrition applications
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
The generous donation includes multiple medical equipments
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Subscribe To Our Newsletter & Stay Updated
